Method for agonizing a dopamine receptor

Details Method for agonizing a dopamine receptor Method for agonizing a dopamine receptor

1991-01-08

1991-10-15

Ramsuer, Robert W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514210, 514212, 514218, 514254, 514292, A61K 31435, A61K 31445, A61K 31535

Patent

active

050575155

ABSTRACT:
Trans-(.+-.)-2-(substituted)-6-(substituted)-5,5a,6,7,8,9,9a,10-octahydropy rido[2,3-g]quinolines are useful in treating a variety of disorders including Parkinsonism, anxiety, depression, hypertension, glaucoma, sexual dysfunction, and prolactin mediated disorders such as galactorrhea, amenorrhea, prolactinoma and the inhibition of postpartum lactation.

REFERENCES:
patent: 3790577 (1974-02-01), Waring
patent: 4198415 (1980-04-01), Kronfeld et al.
patent: 4235909 (1980-11-01), Bach et al.
patent: 4501890 (1985-02-01), Nichols et al.
patent: 4537893 (1985-08-01), Titus et al.
patent: 4659832 (1987-04-01), Schaus et al.
Bach et al., J. Med. Chem., 23, 481 (1980).
Nordman et al., J. Med. Chem., 28(3), 367 (1985).

Affiliated with

Also associated with

Rating

Method for agonizing a dopamine receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for agonizing a dopamine receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for agonizing a dopamine receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-991407